ACSL4 and prostate neoplasm: All together, our findings reveal the regulation of ferroptosis by the RB/E2F/ACSL4 axis and highlight the therapeutic potential of ferroptosis induction in the treatment of RB1 loss–driven prostate tumor growth and metastasis and perhaps other RB1-deficient malignancies.